截至10:05，恒生港股通创新药指数上涨0.1%，中证港股通医药卫生综合指数上涨0.2%，两只指数共有的成分股中，和黄医药涨超4%，绿叶制药涨超3%。近日，我国创新药产业迎来多项突破性进展。从多款创新药集中获批上市，到企业在国际学术舞台展示亮眼临床数据、出海交易金额屡创新高，行业活力尽显。据医药魔方和东吴证券的测算，2024年中国创新药市场总规模近5500亿元人民币，2025年~2027年依靠BD...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.